UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Strategic Education
STRA
$1.94B
| $3.11M | ﹤0.01% |
36,127
-33,623
| -48% | -$2.71M |
|
1577
Liberty Latin America Class C
LILAK
$1.5B
| $3.09M | ﹤0.01% |
403,088
-221,940
| -36% | -$1.52M |
|
1578
Northwest Bancshares
NWBI
$2.2B
| $3.09M | ﹤0.01% |
249,084
-172,238
| -41% | -$2.17M |
|
1579
Vertex
VERX
$2.1B
| $3.08M | ﹤0.01% |
124,180
-79,435
| -39% | -$2.3M |
|
1580
Harmonic Inc
HLIT
$1.48B
| $3.08M | ﹤0.01% |
302,303
-210,915
| -41% | -$1.99M |
|
|
DMC
1581
Del Monte Corp
DMC
$1.34B
| $3.08M | ﹤0.01% |
88,608
-84,473
| -49% | -$2.99M |
|
1582
Trupanion
TRUP
$1.19B
| $3.07M | ﹤0.01% |
70,918
-43,161
| -38% | -$2.05M |
|
1583
Enovix
ENVX
$1.08B
| $3.07M | ﹤0.01% |
307,494
-347,675
| -53% | -$3.85M |
|
1584
Interface
TILE
$1.88B
| $3.05M | ﹤0.01% |
105,552
-74,707
| -41% | -$1.88M |
|
|
SCS
1585
DELISTED
Steelcase
SCS
| $3.03M | ﹤0.01% |
176,191
-152,772
| -46% | -$2.21M |
|
|
PRA
1586
DELISTED
ProAssurance
PRA
| $3.03M | ﹤0.01% |
126,234
-79,652
| -39% | -$1.9M |
|
1587
Federal Agricultural Mortgage
AGM
$2.2B
| $3.02M | ﹤0.01% |
17,952
-16,564
| -48% | -$3.1M |
|
1588
Protolabs
PRLB
$1.78B
| $3.01M | ﹤0.01% |
60,237
-41,194
| -41% | -$1.89M |
|
1589
TripAdvisor
TRIP
$1.68B
| $3.01M | ﹤0.01% |
184,857
-153,247
| -45% | -$2.67M |
|
1590
PAR Technology
PAR
$709M
| $3M | ﹤0.01% |
75,829
-60,541
| -44% | -$3.34M |
|
1591
Viridian Therapeutics
VRDN
$2.1B
| $3M | ﹤0.01% |
138,980
-51,124
| -27% | -$922K |
|
1592
BioCryst Pharmaceuticals
BCRX
$2.52B
| $3M | ﹤0.01% |
394,740
-297,229
| -43% | -$2.48M |
|
1593
Tilray
TLRY
$551M
| $3M | ﹤0.01% |
173,165
-160,391
| -48% | -$1.53M |
|
1594
Array Technologies
ARRY
$941M
| $2.97M | ﹤0.01% |
364,127
-299,563
| -45% | -$2.27M |
|
1595
Worthington Enterprises
WOR
$2.65B
| $2.96M | ﹤0.01% |
53,416
-52,342
| -49% | -$3.3M |
|
1596
Vericel Corp
VCEL
$2.43B
| $2.95M | ﹤0.01% |
93,662
-69,288
| -43% | -$2.49M |
|
1597
Standard Motor Products
SMP
$838M
| $2.95M | ﹤0.01% |
72,193
-29,871
| -29% | -$1.09M |
|
1598
Insperity
NSP
$1.85B
| $2.94M | ﹤0.01% |
59,780
-44,280
| -43% | -$2.42M |
|
1599
Arlo Technologies
ARLO
$1.42B
| $2.94M | ﹤0.01% |
173,495
-102,327
| -37% | -$1.74M |
|
1600
Teladoc Health
TDOC
$1.74B
| $2.93M | ﹤0.01% |
379,446
-290,083
| -43% | -$2.26M |
|
Similar funds
